Avience Biomedicals Limited (NSE:AVIENCE)
India · Delayed Price · Currency is INR 280.35
-5.50 (-1.92%)
At close: Jul 14, 2026
Avience Biomedicals Revenue
In the fiscal year ending March 31, 2025, Avience Biomedicals had annual revenue of 452.36M INR with 88.77% growth. Avience Biomedicals had revenue of 122.35M in the quarter ending March 31, 2025.
Revenue
452.36M
Revenue Growth
+88.77%
P/S Ratio
3.40
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.54B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 452.36M | 212.72M | 88.77% |
| Mar 31, 2024 | 239.64M | 130.38M | 119.32% |
| Mar 31, 2023 | 109.26M | 7.79M | 7.68% |
| Mar 31, 2022 | 101.48M | 90.14M | 795.59% |
| Mar 31, 2021 | 11.33M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jay Jalaram Technologies | 8.52B |
| Digicontent | 4.89B |
| AVP Infracon | 4.41B |
| Reliable Data Services | 1.85B |
| De Neers Tools | 1.78B |
| Bharat Road Network | 1.54B |
| Rockingdeals Circular Economy | 1.20B |
| Oneclick Logistics India | 1.15B |